Pharmaceuticals, Biotechnology and Life Sciences
SENS-111 phase 2 AUV trial: major progress with 75% of patients enrolled in the clinical trial assessing the efficacy of…
BETHESDA, Md.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/Hyalolex?src=hash” target=”_blank”gt;#Hyalolexlt;/agt;–India Globalization Capital, Inc. (NYSE:IGC) announces today that, as of Wednesday, March 27, 2019, Hyalolex™, the…
First prophylactic vaccine to demonstrate proof of concept for CMV control independent of human leukocyte antigen (HLA) status in stem…
Leonard Brings Significant Expertise in Technology, Procurement and Supply Chain PORTLAND, Maine–(BUSINESS WIRE)–Covetrus (NASDAQ: CVET), a global leader in animal-health…
Serum Institute of India completes a Phase 3 clinical trial with chemistry developed by Fina Biosolutions ROCKVILLE, Md.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/pneumococcal?src=hash”…
Leading automated medication management company brings on industry experts to increase impact amongst hospitals across the United States WASHINGTON–(BUSINESS WIRE)–Kit…
Funding in excess of US$1 million to support the development of a brain imaging probe for patient diagnosis and the…
CAMBRIDGE, Mass.–(BUSINESS WIRE)—-Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism…
The study was presented at ENDO 2019, Endocrine Society’s annual meeting DUARTE, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CityofHope?src=hash” target=”_blank”gt;#CityofHopelt;/agt;–The hemoglobin A1c blood test…
SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the…